Programmed death receptor-1 (PD-1) negatively regulates antigen receptor signaling upon binding to its ligands, programmed death-ligand 1 or 2 (PD-L1/2), enabling tumor cells to evade immune surveillance. Here, CD274 is linked to neoplasm.